Laboratory of Dietetics and Clinical Nutrition, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.
Scuola di Specializzazione in Scienza dell'Alimentazione, Università degli Studi di Milano, Milano, Italy.
Child Obes. 2024 Jan;20(1):48-67. doi: 10.1089/chi.2022.0035. Epub 2023 Aug 14.
Celiac disease (CD) is a multifactorial, immune-mediated enteropathic disorder that may occur at any age with heterogeneous clinical presentation. In the last years, unusual manifestations have become very frequent, and currently, it is not so uncommon to diagnose CD in subjects with overweight or obesity, especially in adults; however, little is known in the pediatric population. This systematic review aims to evaluate the literature regarding the association between CD and overweight/obesity in school-age children. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed. An electronic database search of articles published in the last 20 years in English was carried out in Web of Sciences, PubMed, and Medline. The quality of the included studies was assessed by using the STrengthening the Reporting of OBservational studies in Epidemiology statement. Of the 1396 articles identified, 9 articles, investigating overweight/obesity in children/adolescents affected by CD or screening CD in children/adolescents with overweight/obesity, met the inclusion criteria. Overall, the results showed that the prevalence of overweight or obesity in school-age children (6-17 years) affected by CD ranged between 3.5% and 20%, highlighting that the coexistence of CD with overweight/obesity in children is not uncommon as previously thought. Although CD has been historically correlated with being underweight due to malabsorption, it should be evaluated also in children with overweight and obesity, especially those who have a familiar predisposition to other autoimmune diseases and/or manifest unusual symptoms of CD.
乳糜泻(CD)是一种多因素、免疫介导的肠病,可发生于任何年龄,临床表现具有异质性。近年来,不常见的表现变得非常频繁,目前,超重或肥胖患者,尤其是成年人中诊断 CD 并不罕见;然而,在儿科人群中,这方面的知识相对较少。本系统评价旨在评估有关 CD 与学龄儿童超重/肥胖之间关联的文献。本研究遵循系统评价和荟萃分析的首选报告项目(PRISMA)指南。在 Web of Sciences、PubMed 和 Medline 中对过去 20 年发表的英文文章进行了电子数据库检索。使用强化观察性研究报告的流行病学(STROBE)声明评估纳入研究的质量。在确定的 1396 篇文章中,有 9 篇文章符合纳入标准,调查了患有 CD 的儿童/青少年超重/肥胖,或对超重/肥胖的儿童/青少年进行 CD 筛查。总体而言,结果表明,患有 CD 的学龄儿童(6-17 岁)超重或肥胖的患病率在 3.5%至 20%之间,这表明以前认为的 CD 与超重/肥胖共存并不罕见。尽管 CD 由于吸收不良而与体重不足相关,但也应在超重和肥胖的儿童中进行评估,尤其是那些有其他自身免疫性疾病家族易感性和/或表现出不典型 CD 症状的儿童。